Supplementary Figure S1 from CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance
Year: 2026
Type: supplementary-materials
Abstract: Validation of PC3-IIICS-FN-KO and PC3-GALNT6-KO lines and associated transcriptional and in vivo phenotypes.
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7205010508
